Dr Heather Ann Petersohn Miller, AUD in Kenosha, WI - Audiologist-Hearing Aid Fitter

Dr Heather Ann Petersohn Miller, AUD is a Audiologist-hearing Aid Fitter based in Kenosha, Wisconsin. Dr Heather Ann Petersohn Miller is licensed to practice in Wisconsin (license number 355-156) and her current practice location is 6308 8th Ave, Suite 3000, Kenosha, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (262) 656-3300.

NPI number for Dr Heather Ann Petersohn Miller is 1780748269 and her current mailing address is 6308 8th Ave, Suite 3000, Kenosha, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1780748269.

Contact Information

	Dr Heather Ann Petersohn Miller, AUD
	6308 8th Ave, Suite 3000, Kenosha, WI 53143-5031
	(262) 656-3300
	(262) 656-3265

Healthcare Provider's Profile

Full Name	Dr Heather Ann Petersohn Miller
Gender	Female
Speciality	Audiologist-hearing Aid Fitter
Location	6308 8th Ave, Kenosha, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1780748269
Provider Enumeration Date: 12/20/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Heather Ann Petersohn Miller such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1780748269	NPI	-	NPPES
41140100	Medicaid	WI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	355-156 (Wisconsin)	Primary
231HA2400X	Audiologist - Assistive Technology Practitioner	355-156 (Wisconsin)	Primary
231HA2500X	Audiologist - Assistive Technology Supplier	355-156 (Wisconsin)	Primary
237600000X	Audiologist-hearing Aid Fitter	355-156 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Heather Ann Petersohn Miller is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Heather Ann Petersohn Miller, AUD 6308 8th Ave, Suite 3000, Kenosha, WI 53143-5031 Ph: (262) 656-3300	Dr Heather Ann Petersohn Miller, AUD 6308 8th Ave, Suite 3000, Kenosha, WI 53143-5031 Ph: (262) 656-3300

News Archive

Pall enters new $500 million 5-year revolving credit facility

Pall Corporation today announced that it has entered into a new $500 million five-year revolving credit facility. The new facility replaces the Company's $500 million revolver that was due to expire in June 2011. This transaction follows on the recent refinancing of the Company's $280 million senior notes due in 2012 with proceeds of senior notes now due in 2020.

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Sheffield academic receives funding to protect brain cells affected by Parkinson's

A Sheffield academic has been awarded £100,000 of funding by the Virtual Biotech Programme - the drug development arm of charity Parkinson's UK - to develop a new treatment that could protect brain cells affected by Parkinson's disease, potentially slowing, or stopping its progression for the first time.

New therapeutic approach for aggressive breast cancer

This type of TNBC tumor does not express any of the receptors involved in most breast cancers (estrogen, progesterone and HER2), so the most common treatments, such as the hormone therapy, are not viable in these patients.

Dr Heather Ann Petersohn Miller, AUD - in Kenosha, WI